Navigation path

CSR - REACH Authorisation decisions - OPnEO - Bio-Rad - Uses 1-2-3-4
CSR - REACH Authorisation decisions - 4-NPnEO - Bio-Rad
REACH - List of Amendments to Annex XIV - Authorisations
COMMISSION STAFF WORKING DOCUMENT Restrictions Roadmap under the Chemicals Strategy for Sustainability
Authorisation Decisions List
CSR - REACH Authorisation decisions - Chromium trioxide - Safran
Draft agenda - Detergents Revision Stakeholders workshop - 12 May 2022
COMMISSION IMPLEMENTING DECISION of 11.4.2022 granting an authorisation under Regulation (EC) No 1907/2006 of the European Parliament and of the Council to DIAGAST for a use of 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (4-tert-OPnEO)
DÉCISION D’EXÉCUTION DE LA COMMISSION du 11.4.2022 accordant une autorisation au titre du règlement (CE) nº 1907/2006 du Parlement européen et du Conseil à DIAGAST pour une utilisation du 4-(1,1,3,3-tétraméthylbutyl)phénol, éthoxylé (4-tert-
COMMISSION IMPLEMENTING DECISION of 11.4.2022 granting an authorisation under Regulation (EC) No 1907/2006 of the European Parliament and of the Council to Hospira Zagreb d.o.o., a Pfizer company for a use of 4-tert-OPnEO
COMMISSION IMPLEMENTING DECISION of 8.4.2022 granting an authorisation under Regulation (EC) No 1907/2006 of the European Parliament and of the Council to bioMérieux SA for a use of 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (4-tert-OPnEO)
COMMISSION IMPLEMENTING DECISION of 8.4.2022 granting an authorisation under Regulation (EC) No 1907/2006 of the European Parliament and of the Council to DiaSorin S.p.A. for a use of 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (4-tert-OPnEO)
COMMISSION DECISION of 8.4.2022 on the termination of the restrictions process on cobalt sulphate, cobalt dichloride, cobalt dinitrate, cobalt carbonate and cobalt di(acetate) under REACH
CSR - REACH Authorisation decisions - OPnEO - Merck KGaA
CSR - REACH Authorisation decisions - OPnEO - Vetter Pharma
CSR - REACH Authorisation decisions - OPnEO - BioMérieux - Uses 2-3
CSR - REACH Authorisation decisions - Chromic acid - Neoperl
CSR - REACH Authorisation decisions - EDC - EURENCO Rev
REACH - List of Amendments to Annex XVII - Restrictions
COMMISSION IMPLEMENTING DECISION of 17.3.2022 granting an authorisation under Regulation (EC) No 1907/2006 of the European Parliament and of the Council to Sanofi Pasteur for a use of 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated
COMMISSION IMPLEMENTING DECISION of 17.3.2022 granting an authorisation under Regulation (EC) No 1907/2006 of the European Parliament and of the Council to Diagnostica Stago for certain uses of4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated
COMMISSION IMPLEMENTING DECISION of 17.3.2022 granting an authorisation under Regulation (EC) No 1907/2006 of the European Parliament and of the Council to Kedrion S.p.A for a use of 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated
COMMISSION IMPLEMENTING DECISION of 17.3.2022 granting an authorisation under Regulation (EC) No 1907/2006 of the European Parliament and of the Council to Rentschler Biopharma SE for a use of 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (4-tert-OPnEO
COMMISSION IMPLEMENTING DECISION of 17.3.2022 granting an authorisation under Regulation (EC) No 1907/2006 of the European Parliament and of the Council to Sekisui S-lec BV Roermond for a use of 4-Nonylphenol, branched and linear, ethoxylated
COMMISSION IMPLEMENTING DECISION of 17.3.2022 granting an authorisation under Regulation (EC) No 1907/2006 of the European Parliament and of the Council to SEBIA for a use of 4-Nonylphenol, branched andlinear, ethoxylated
Resultados por página: 5 10 15 20 25 | Página 1 de 43

Additional tools